Abstract
Introduction/objectives
Cutaneous involvement is often overlooked in rheumatoid arthritis (RA). We described cutaneous findings in outpatients attending a recent-onset cohort and identified factors associated with skin involvement and reduced (R) dermatological quality of life (DQoL).
Methods
Skin and rheumatological examinations were performed in 122 patients. DQoL was assessed through the Dermatology Life Quality Index (DLQI). Skin findings were classified as RA-specific and RA-nonspecific. Multiple regression analysis identified factors associated to skin involvement and RDQoL (DLQI score > 1).
Results
Patients were middle-aged females (91%), with a 1-year mean disease activity score in 28 joints as 2.0 (interquartile range: 1.5–2.6). There were 94 (77%) patients in whom at least one cutaneous finding was observed: 17 (13.1%) had RA-specific findings (all were rheumatoid nodules) and 91 (96.8%) had at least one RA-nonspecific finding, further classified into skin diseases (35.2%), hair diseases (20.9%), and skin-related signs (76.9%, among whom 94.3% had xerosis). Age (odds ratio [OR]: 1.054, 95% confidence interval [CI]: 1.015–1.094) and skin-health concerns (OR: 5.657, 95% CI: 1.771–18.070) were associated with cutaneous involvement, whereas increased age and DLQI score were associated with a higher number of skin findings/patient. There were 29 patients (24.2%) with RDQoL, which were associated with the Short Form-36 emotional component (OR: 0.955, 95% CI: 0.923–0.988) and the number of skin findings/patient (OR 2.873, 95% CI 1.723–4.791). Pruritus and hair diseases were the individual categories associated with RDQoL.
Conclusions
Cutaneous manifestations are frequent in RA patients and have the potential to impact the emotional component of health-related quality of life.
Key Points • Up to 77% of the RA patients with substantial follow-up, from a recent-onset disease cohort, had cutaneous manifestations; these were primarily RA-nonspecific findings, whereas 13.1% had RA-specific findings. • Skin-health concerns and age were associated with cutaneous involvement; meanwhile, increased age and Dermatology Life Quality Index (DLQI) score were associated with a higher number of cutaneous findings/patient. • Reduced dermatological quality of life (RDQoL) was documented in one in four patients and was associated with the SF-36 emotional component and the number of cutaneous findings/patient. |
Similar content being viewed by others
References
Smolen J, Aletaha D, Mclnnes I (2007) Rheumatoid arthritis. Lancet 388:2023–2038. https://doi.org/10.1016/S0140-6736(16)30173-8
Turesson C, Eberhardt K, Jacobsson LT, Lindqvist E (2007) Incidence and predictors of severe extra-articular disease manifestations in an early rheumatoid arthritis inception cohort. Ann Rheum Dis 66:1543–1544. https://doi.org/10.1136/ard.2007.076521
Contreras-Yáñez I, Lavielle P, Clark P, Pascual-Ramos V (2019) Validation of a risk perception questionnaire developed for patients with rheumatoid arthritis. PLoS One 14:E0219921. https://doi.org/10.1371/journal.pone.0219921
Cardiel MH, Pons-Estel BA, Sacnun MP, Wojdyla D, Saurit V, Marcos JC, Pinto MR, Cordeiro de Azevedo AB, da Silveira IG, Radominski SC, Ximenes AC, Massardo L, Ballesteros F, Rojas-Villarraga A, Oñate RV, Hernandez MP, Esquivel-Valerio JA, García-de la Torre I, Khoury VJ, Millán A, Soriano ER, GLADAR (2012) Treatment of early rheumatoid arthritis in a multinational inception cohort of Latin American patients: the GLADAR experience. J Clin Rheumatol 18:327–335. https://doi.org/10.1097/RHU.0b013e31826d6610
Lora V, Cerroni L, Cota C (2018) Skin manifestations of rheumatoid arthritis. J Ital Dermatol Venereol 153:243–255. https://doi.org/10.1111/j.1346-8138.1995.tb03396.x
Xue Y, Cohen JM, Wright NA, Merola JF (2016) Skin signs of rheumatoid arthritis and its therapy induced cutaneous side effects. Am J Clin Dermatol 17:147–162. https://doi.org/10.1007/s40257-015-0167-z
Sayah A, English JC 3rd (2005) Rheumatoid arthritis: a review of the cutaneous manifestations. J Am Acad Dematol 53:191–209. https://doi.org/10.1016/j.jaad.2004.07.023
Fazel M, Merola JF, Kurtzman DJB (2018) Inflammatory arthritis and crystal arthropathy: current concepts of skin and systemic manifestations. Clin Dermatol 36:533–550
Finlay AY, Ryan TJ (1996) Disability and handicap in dermatology. Int J Dermatol 35:305–311. https://doi.org/10.1111/j.1365-4362.1996.tb03628.x
Basra MK, Fenech R, Gatt RM, Salek MS, Finlay AY (2008) The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. Br J Dermatol 159:997–1035. https://doi.org/10.1111/j.1365-2133.2008.08832.x
Prevoo ML, van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48. https://doi.org/10.1002/art.1780380107
Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383. https://doi.org/10.1016/0021-9681(87)90171-8
Maska L, Anderson J, Michaud K (2011) Measures of functional status and quality of life in rheumatoid arthritis. Health Assessment Questionnaire Disability Index (HAQ), Modified Health Assessment Questionnaire (MHAQ), Multidimensional Health Assessment Questionnaire (MDHAQ), Health Assessment Questionnaire II (HAQ-II), Improved Health Assessment Questionnaire (Improved HAQ) And Rheumatoid Arthritis Quality of Life (RAQoL). Arthritis Care Res 63(Suppl 11):S4–S13. https://doi.org/10.1002/acr.20620
Sánchez-Cárdenas G, Contreras-Yáñez I, Méndez-Flores S et al (2020) Toenail abnormalities in rheumatoid arthritis patients are associated with radiographic damage and impact disability: a cohort study. Clin Exp Rheumatol (In press 23 Jun 2020).
Arnett FC, Edworthy SM, Bloch DA, Mcshane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324. https://doi.org/10.1002/art.1780310302
Aletaha D, Neogi T, Silman AJ et al (2010) Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative [published correction appears in Ann Rheum Dis. 2010 Oct;69(10):1892]. Ann Rheum Dis 69:1580–1588. https://doi.org/10.1136/ard.2010.138461
Wong NWK, Towheed TE, Hopman W, Kirchhof MG (2018) Detection of dermatological abnormalities in the rheumatology clinic using s standardized screening exam. Int J Rheum Dis 21:387–393. https://doi.org/10.1111/1756-185X.13114
Durán-Arenas L, Gallegos-Carrillo K, Salinas-Escudero G, Martínez-Salgado H (2004) Hacia una base normativa mexicana en la medición de calidad de vida relacionada con la salud, mediante el Formato Corto 36 [Towards a Mexican normative standard for measurement of the short format 36 health-related quality of life instrument]. Salud Publica Mex 46:306–315. https://doi.org/10.1590/s0036-36342004000400005
Chua-Aguilera CJ, Möller B, Yawalkar N (2017) Skin manifestations of rheumatoid arthritis, juvenile idiopathic arthritis, and spondyloarthritides. Clin Rev Allergy Immunol 53:371–393. https://doi.org/10.1007/s12016-017-8632-5
Douglas KM, Ladoyanni E, Treharne GJ, Hale ED, Erb N, Kitas GD (2006) Cutaneous abnormalities in rheumatoid arthritis compared with non-inflammatory rheumatic conditions. Ann Rheum Dis 65:1342–1345. https://doi.org/10.1136/ard.2005.048934
Hata T, Kavanaugh A (2006) Rheumatoid arthritis in rheumatology. Clin Dermatol 24:430–437. https://doi.org/10.1016/j.clindermatol.2006.07.008
Yamamoto T (2009) Cutaneous manifestations associated with rheumatoid arthritis. Rheumatol Int 29:979–988. https://doi.org/10.1007/s00296-009-0881-z
Nyhäll-Wåhlin BM, Turesson C, Jacobsson LT, Nilsson JÅ, Forslind K, Albertsson K, Rönnelid J, Petersson IF, for the BARFOT study group (2011) The presence of rheumatoid nodules at early rheumatoid arthritis diagnosis is a sign of extra-articular disease and predicts radiographic progression of joint destruction over 5 years. Scand J Rheumatol 40:81–87. https://doi.org/10.3109/03009742.2010.509103
Chapeskie H (2008) Ingrown toenail or overgrown toe skin?: alternative treatment for onychocryptosis. Can Fam Physician 54:1561–1562
Hamilton EB (1960) Nail studies in rheumatoid arthritis. Ann Rheum Dis 19:167–173. https://doi.org/10.1136/ard.19.2.167
Maddy AJ, Tosti A (2018) Hair and nail diseases in the mature patient. Clin Dermatol 36:159–166. https://doi.org/10.1016/j.clindermatol.2017.10.007
Totoson P, Maguin-Gaté K, Prati C, Wendling D, Demougeot C (2014) Mechanisms of endothelial dysfunction in rheumatoid arthritis: lessons from animal studies. Arthritis Res Ther 16:202. https://doi.org/10.1186/ar4450
Lewis V, Finlay AY (2004) 10 years experience of the Dermatology Life Quality Index (DLQI). J Investig Dermatol Symp Proc 9:169–180. https://doi.org/10.1111/j.1087-0024.2004.09113.x
Council ML (2018) Quality of life and the dermatologist. JAMA Dermatol 154:654–655. https://doi.org/10.1001/jamadermatol.2018.0001
Valderas JM, Kotzeva A, Espallargues M, Guyatt G, Ferrans CE, Halyard MY, Revicki DA, Symonds T, Parada A, Alonso J (2008) The impact of measuring patient-reported outcomes in clinical practice: a systematic review of the literature. Qual Life Res 17:179–193. https://doi.org/10.1007/s11136-007-9295-0
Finlay AY, Salek MS, Abeni D, Tomás-Aragonés L, van Cranenburgh OD, Evers AWM, Jemec GBE, Linder D, Manolache L, Marrón SE, Prinsen CAC, Susitaival P, Chernyshov PV, the EADV Task Force on Quality of Life (2017) Why quality of life measurement is important in dermatology clinical practice: an expert-based opinion statement by the EADV Task Force on quality of life. J Eur Acad Dermatol Venereol 31:424–431. https://doi.org/10.1111/jdv.13985
Finlay AY (1993) Psychological impact of skin disease. In: Seymour CA, Hegarty AM (eds) Horizons in Medicine 4. McGraw-Hill, London, pp 172–179
Williamson D, Gonzalez M, Finlay AY (2001) The effect of hair loss on quality of life. J Eur Acad Dermatol Venereol 15:137–139
Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP, Margolis DJ, Marks R, Naldi L, Weinstock MA, Wulf SK, Michaud C, J.L. Murray C, Naghavi M (2014) The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol 134:1527–1534. https://doi.org/10.1038/jid.2013.446
Pereira MP, Ständer S (2017) Assessment of severity and burden of pruritus. Allergol Int 66:3–7. https://doi.org/10.1016/j.alit.2016.08.009
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
None.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sánchez-Cárdenas, G., Contreras-Yáñez, I., Guaracha-Basáñez, G. et al. Cutaneous manifestations are frequent and diverse among patients with rheumatoid arthritis and impact their quality of life: a cross-sectional study in a cohort of patients with recent-onset disease. Clin Rheumatol 40, 3581–3590 (2021). https://doi.org/10.1007/s10067-021-05664-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-021-05664-0